APPLICATION
ANDA206569
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-27
LATEST ACTION
2025-01-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
TENOFOVIR DISOPROXIL FUMARATEDiscontinued
TENOFOVIR DISOPROXIL FUMARATE 300MG · TABLET · ORAL
TENOFOVIR DISOPROXIL FUMARATEDiscontinued
TENOFOVIR DISOPROXIL FUMARATE 200MG · TABLET · ORAL
TENOFOVIR DISOPROXIL FUMARATEDiscontinued
TENOFOVIR DISOPROXIL FUMARATE 250MG · TABLET · ORAL
TENOFOVIR DISOPROXIL FUMARATEDiscontinued
TENOFOVIR DISOPROXIL FUMARATE 150MG · TABLET · ORAL
Approval history
2025-01-28Labeling · Supplement 2 · standardAP
2025-01-28Labeling · Supplement 1 · standardAP
2018-11-27UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.